"At Yale New Haven Health, we deliver extraordinary, compassionate care by working alongside providers and payers on innovative, cost-effective healthcare delivery models that improve care and value for patients - and enhance the health of our communities."

During the past decade, Yale New Haven Hospital Saint Raphael Campus conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 22 clinical trials were completed, i.e. on average, 110% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 14 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yale New Haven Hospital Saint Raphael Campus" #1 sponsor was "Radiation Therapy Oncology Group" with 18 trials, followed by "Yale University" with 13 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "National Cancer Institute (NCI)" with 4 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale New Haven Hospital Saint Raphael Campus" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Yale New Haven Hospital Saint Raphael Campus" are "Head and Neck Cancer" (5 trials), "Prostate Cancer" (5 trials), "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Breast Cancer" (4 trials) and "Lung Cancer" (4 trials). Many other conditions were trialed in "Yale New Haven Hospital Saint Raphael Campus" in a lesser frequency.

Most popular intervention types in "Yale New Haven Hospital Saint Raphael Campus" are "Drug" (37 trials), "Radiation" (19 trials), "Other" (17 trials), "Procedure" (15 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (15 trials), "Laboratory Biomarker Analysis" (9 trials), "conventional surgery" (6 trials), "cisplatin" (5 trials) and "paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Yale New Haven Hospital Saint Raphael Campus" are 46 trials for "All" genders, 7 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Yale New Haven Hospital Saint Raphael Campus". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Yale New Haven Hospital Saint Raphael Campus, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Yale New Haven Hospital Saint Raphael Campus, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".